CoreWeave Inc. (Nasdaq: CRWV) has emerged as one of 2025's most compelling technology stories, transforming from a cryptocurrency mining operation into a $39 billion market-cap AI cloud computing powerhouse. As artificial intelligence reshapes global technology infrastructure, CoreWeave has positioned itself as "The Essential Cloud for AI," providing specialized Graphics Processing Unit (GPU) infrastructure that powers [...]
Date: 12/10/2025 1. Introduction As of December 10, 2025, Tesla Inc. (NASDAQ: TSLA) remains a company of intense focus and significant global relevance, transcending its origins as an electric vehicle (EV) manufacturer to become a pivotal player in artificial intelligence (AI), robotics, and sustainable energy solutions. Headquartered in Austin, Texas, Tesla’s multifaceted operations span the [...]
Shares of luxury electric car manufacturer Lucid (NASDAQ:LCID) fell 4.3% in the afternoon session after the company launched its first certified pre-owned vehicle program, "Lucid Recharged," but investor focus remained on broader financial concerns. The new program aimed to offer customers more choice with manufacturer-backed standards. However, the announcement did not impress investors, who seemed more concerned with the electric vehicle maker's underlying financial health. The move followed a recent downgrade from Morgan Stanley to "Underweight," which cited worries that the company might not achieve profitability until 2028. Additionally, Lucid previously adjusted its 2025 production guidance downward.
Shares of online platform company Coupang (NYSE:CPNG)
fell 5.1% in the afternoon session after the company faced mounting pressure from the fallout of a major data breach that led to the CEO's resignation.
Shares of semiconductor equipment maker Lam Research (NASDAQ:LRCX)
jumped 3.2% in the afternoon session after an analyst at Jefferies maintained the company's "Buy" rating and raised its price target. The analyst, Blayne Curtis, increased the price target for the semiconductor equipment maker to $200 from $175, a lift of over 14%. This action, combined with the reaffirmed positive rating, reflected growing confidence in Lam Research's market performance and future growth prospects within the semiconductor industry.
Shares of semiconductor quality control company Nova (NASDAQ:NVMI) jumped 3.3% in the afternoon session after Jefferies raised its price target on the stock and Morgan Stanley initiated coverage, reinforcing investor confidence.
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY)
jumped 3.7% in the afternoon session after BofA Securities upgraded the company's stock from "Neutral" to "Buy" and increased its price target.
Shares of electric vehicle pioneer Tesla (NASDAQ:TSLA) jumped 3.8% in the afternoon session after Wedbush analyst Dan Ives reiterated his $600 price target, declaring 2026 a pivotal "monster year" for the EV giant.
December 15, 2025 – The dynamic semiconductor sector is currently experiencing a period of intense growth, primarily fueled by the relentless demand for Artificial Intelligence (AI) and high-performance computing (HPC). As the industry charges towards a projected trillion-dollar valuation by 2030, individual company performances are painting a nuanced picture of success and caution. Recent financial [...]
Shares of electric vehicle manufacturer Rivian (NASDAQ:RIVN) jumped 14.1% in the afternoon session after the company announced ambitious plans for autonomous driving technology, including a proprietary AI chip, during its inaugural Autonomy & AI Day.
From a Musk-like compensation for its CEO to an Autonomy & AI Day, Rivian has borrowed several leaves from Tesla's playbook. But is RIVN stock a better buy than TSLA for 2026?
Wall Street is undergoing a profound transformation, not by shedding its tech talent, but by aggressively absorbing it. What some are terming a "Tech Exodus" is, in fact, an AI-driven influx of highly specialized technologists into the financial sector, fundamentally reshaping its workforce and capabilities. This pivotal shift is occurring against a backdrop of unprecedented [...]
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY)
jumped 2.6% in the afternoon session after an analyst at Guggenheim upgraded the company's stock from "Neutral" to "Buy" and set a new price target of $62.
Business Insider reported on Friday, citing an internal list of upcoming price changes sent to company staff on December 9, that the price hikes will impact Dell’s commercial business.
